arrow
E

Eunate Arana-Arri

hospital universitario cruces
H指数:27
被引数:3,865

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strengthening cancer prevention in european schools: a randomized controlled trial of digital interventions in adolescents: the SUNRISE program

加强欧洲学校的癌症预防:针对青少年数字干预措施的随机对照试验:SUNRISE项目

2026-06-250
OAAI
Understanding LUng Cancer risk factors and their Impact Assessment (LUCIA): protocol for multicentre observational cohort study

理解肺癌风险因素及其影响评估(LUCIA):多中心观察性队列研究方案

2026-05-040
PRE
Efficacy of an instant messaging-based life-skills training program to prevent behavioral risk factors among adolescents in Europe: study protocol of a cluster-randomized controlled trial

基于即时通讯的生活技能培训项目在预防欧洲青少年行为风险因素中的有效性:一项集群随机对照试验的研究方案

2025-11-240
OAAI
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohorts

年龄和性别特异的脂蛋白谱在一般和心血管代谢人群队列中的研究

2025-11-080
OAAI
Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study

PHH-1V加强针针对SARS-CoV-2变种(包括奥密克戎亚变种)的安全性与免疫原性:一项IIb期开放标签扩展研究的结果

2025-04-300
OAAI
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

Omicron XBB.1.16-适用于新型冠状病毒肺炎的疫苗: 临时免疫原性和安全性临床试验结果

2024-07-250
OAAI
GATEKEEPER's Strategy for the Multinational Large-Scale Piloting of an eHealth Platform: Tutorial on How to Identify Relevant Settings and Use Cases
2023-06-285
OA
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

基于蛋白质的PHH-1V与BNT162b2作为异源SARS-CoV-2加强疫苗在成人新型冠状病毒肺炎疫苗中的安全性和免疫原性比较: 多中心,随机,双盲,非劣效性IIb期试验

2023-05-0116
OA
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

用两剂实验性新型冠状病毒肺炎疫苗 (CVnCOV) 预防接种,然后用标准mRNA疫苗 (BNT162b2) 进行第三至第四次注射后的免疫反应和反应原性: RescueVacs多中心队列研究

2022-09-015
OAAI
Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial
2022-08-011
PRE
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
2022-08-014
OAAI
Detailed stratified GWAS analysis for severe COVID-19 in four European populations

对四个欧洲人群的严重新型冠状病毒肺炎进行详细的分层gis分析

2022-07-1548
OAAI